Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Invokana

Canagliflozin

Open in the dashboard

Part D claims

116,409

Prescriptions dispensed, refills included

Drug cost

$98,621,210

Paid at the pharmacy, in all

Prescribers

6,318

With 11 or more claims of it

In 2024, Medicare Part D recorded 116,409 claims for Invokana (canagliflozin) from 6,318 prescribers, at a total drug cost of $98.6 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 53 states and territories
Part D claims for Invokana by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 701 13,840 $11,672,323
NY 512 10,222 $8,844,853
PA 442 8,141 $6,407,544
MI 385 7,245 $8,179,941
FL 272 6,264 $5,382,486
NC 296 5,212 $4,445,594
OH 249 4,428 $3,562,625
IL 241 4,322 $3,747,591
TX 263 4,182 $3,417,570
NJ 196 3,497 $3,558,241
KY 161 3,018 $2,552,308
IN 158 3,009 $2,481,743
MO 156 2,957 $2,170,176
MN 143 2,767 $2,096,220
AL 160 2,639 $2,111,856
The other 38 states and territories
State Prescribers Claims Drug cost
GA 153 2,539 $2,103,548
OK 103 2,299 $1,663,253
TN 111 2,049 $1,640,825
WI 117 1,984 $1,614,807
LA 99 1,887 $1,492,821
KS 96 1,856 $1,274,106
VA 103 1,743 $1,393,405
MS 70 1,493 $1,130,992
IA 75 1,369 $1,131,817
WA 87 1,344 $1,069,947
CO 78 1,303 $1,099,137
WV 67 1,253 $1,262,265
SC 73 1,208 $992,306
NE 69 1,052 $708,328
PR 36 959 $664,072
CT 60 954 $967,822
AZ 60 855 $696,141
MA 53 819 $611,063
MD 50 815 $667,436
AR 48 720 $481,132
NM 32 603 $536,548
OR 37 600 $475,182
HI 31 587 $762,859
SD 35 554 $414,386
NH 33 531 $422,002
NV 28 475 $562,162
ME 26 448 $309,205
DE 28 408 $419,285
MT 22 329 $239,195
ID 21 326 $241,260
UT 16 274 $186,383
ND 20 258 $182,508
RI 11 192 $136,917
VT 10 186 $179,126
AK 10 153 $126,938
DC 6 119 $49,464
WY 8 104 $65,008
AP 1 18 $16,489

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 38
Part D claims for Invokana by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Family Practice 2,106 36,266 $30,038,881
Internal Medicine 1,676 31,698 $25,725,256
Nurse Practitioner 969 16,860 $13,344,822
Endocrinology 694 15,362 $16,737,841
Physician Assistant 439 7,402 $6,242,409
Nephrology 156 2,920 $2,549,612
General Practice 100 2,211 $1,730,856
Geriatric Medicine 19 702 $278,260
Emergency Medicine 21 637 $344,004
Hospitalist 19 398 $283,204
Cardiology 20 342 $327,381
Pediatric Medicine 19 282 $219,252
Pulmonary Disease 8 132 $63,898
Student in an Organized Health Care Education/Training Program 11 132 $86,209
Osteopathic Manipulative Medicine 6 125 $63,323

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Assad Darawal Internal Medicine CA 277 $186,788 None on record
Carlos Figueroa Nunez Endocrinology PR 268 $184,811 None on record
Vipul Garg Internal Medicine PA 202 $36,105 None on record
Don Zwickler Endocrinology NY 154 $126,846 None on record
Julie Bom Conselho Nurse Practitioner FL 153 $106,720 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record